The Global Immuno-oncology Clinical Trials Market size was estimated at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13% from 2022 to 2028. Immunotherapy is becoming increasingly available in clinical trials for early-stage cancer or as a first-line treatment option as clinical research progresses rapidly. […]
